Losartan Potassium + Comparator: amlodipine besylate + Enalapril Maleate
Phase 3Completed 0 watching 0 views this week📈 Rising
72
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Proteinuria
Conditions
Proteinuria
Trial Timeline
Jun 1, 2007 → Mar 1, 2011
NCT ID
NCT00568178About Losartan Potassium + Comparator: amlodipine besylate + Enalapril Maleate
Losartan Potassium + Comparator: amlodipine besylate + Enalapril Maleate is a phase 3 stage product being developed by Organon for Proteinuria. The current trial status is completed. This product is registered under clinical trial identifier NCT00568178. Target conditions include Proteinuria.
Hype Score Breakdown
Clinical
27
Activity
18
Company
5
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00568178 | Phase 3 | Completed |
Competing Products
6 competing products in Proteinuria
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Zibotentan/Dapagliflozin + Dapagliflozin | AstraZeneca | Phase 2 | 52 |
| candesartan cilexetil | AstraZeneca | Phase 3 | 77 |
| Zibotentan/Dapagliflozin + Dapagliflozin | AstraZeneca | Phase 3 | 77 |
| valsartan | Novartis | Approved | 85 |
| Belatacept | Bristol Myers Squibb | Phase 2 | 51 |
| Sparsentan | Travere Therapeutics | Approved | 80 |